Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) sequence, engineered for extended stability. It is studied for its effects on central nervous system signaling and neurotrophic pathways. Principal research areas include cognitive research, neurobiology, and attention-related research models. For in vitro and non-human research only.